R
SYNTHETIC COMMUNICATIONSV
3087
References
[1] For selected reviews, see: doi:10.1039/C0OB00501K(a) Cacchi, S.; Fabrizi, G., Goggiamani
A. Org. Biomol. Chem. 2011, 9, 641–652. (b) Patil, N. T.; Yamamoto, Y. Chem. Rev. 2008,
108, 3395–3442.
[2] (a) Baba, K.; Takeuchi, K.; Dio, M.; Inoue, M.; Kozawa, M. Chem. Pharm. Bull. 1986, 34,
1540–1545. (b) Baba, K.; Takeuchi, K.; Hamasaki, F.; Kozawa, M. Chem. Pharm. Bull.
1986, 34, 595–602. (c) Baba, K.; Takeuchi, K.; Hamasaki, F.; Kozawa, M. Chem. Pharm.
[3] Singh, S. N.; Fletcher, R. D.; Fisher, S. G.; Singh, B. N.; Lewis, H. D.; Deedwania, P. C.;
Massie, B. M.; Colling, C.; Lazzeri, D. Amiodarone in Patients with Congestive Heart
Failure and Asymptomatic Ventricular Arrhythmia. N. Engl. J. Med. 1995, 333, 77–82.
ꢀ
[4] Rizzo, S.; Riviere, C.; Piazzi, L.; Bisi, A.; Gobbi, S.; Bartolini, M.; Andrisano, V.; Morroni,
F.; Tarozzi, A.; Monti, J.-P.; Rampa, A. Benzofuran-Based Hybrid Compounds for the
Inhibition of Cholinesterase Activity, Beta Amyloid Aggregation, and Abeta Neurotoxicity.
[5] (a) Chen, S.-K.; Zhao, P.; Shao, Y.-X.; Li, Z.; Zhang, C.; Liu, P.; He, X.; Luo, H.-B.; Hu,
ꢁ
X.; Bioorg. Med. Chem. Lett. 2012, 22. 3261–3264. (b) Arias, L.; Vara, Y., Cossıo J. Org.
Chem. 2012, 77, 266–275. (c) Celaje, J. A.; Zhang, D.; Guerrero, A. M.; Selke, M. Org.
Lett. 2011, 13, 4846–4849.
[6] Kao, C.-L.; Chern, J.-W. A Novel Strategy for the Synthesis of Benzofuran Skeleton
Neolignans: Application to Ailanthoidol, XH-14, and Obovaten. J. Org. Chem. 2002, 67,
[7] Bazin, M.-A.; Bodero, L.; Tomasoni, C.; Rousseau, B.; Roussakis, C.; Marchand, P.
Synthesis and Antiproliferative Activity of Benzofuran-Based Analogs of Cercosporamide
against Non-Small Cell Lung Cancer Cell Lines. Eur. J. Med. Chem. 2013, 69, 823–832.
[8] (a) Wu, J.; Rush, T. S.; Hotchandani, R.; Du, X.; Geck, M.; Collins, E.; Xu, Z.; Skotnicki,
J.; Levin, J. I.; Lovering, F. Bioorg. Med. Chem. Lett. 2005, 1. 4105–4109. (b) Li, J.; Rush
III T. S.; Li, W.; DeVincentis, D.; Du, X.; Hu, Y.; Thomason, J. R.; Xiang, J. S.; Skotnicki,
J. S.; Tam, S.; et al. Synthesis and SAR of Highly Selective MMP-13 Inhibitors. Bioorg.
[9] (a) Fischer, J.; Savage, G. P.; Coster, M. J.; Org. Lett. 2011, 1, 3376–3379. (b) Inoue, M.;
Carson, M. W.; Frontier, A. J.; Danishefsky, S. J. Total Synthesis and Determination of the
Absolute Configuration of Frondosin B. J. Am. Chem. Soc. 2001, 123, 1878–1889.
[10] (a) Yeung, K.-S.; Yang, Z.; Peng, X.-S.; Hou, X.-L. In Progress in Heterocyclic Chemistry;
Gribble, G. W., Joule, J. A., Eds.; Elsevier: Oxford, UK, 2011.; Vol. 22, pp 181–216; doi:
[11] For selected examples on benzofuran synthesis under metal catalysis, see: (a) Liu, Y.;
Wang, H.; Wan, J.-P. J. Org. Chem. 2014, 7, 10599–10604. (b) Lee, J. H.; Kim, M.; Kim, I.
J. Org. Chem. 2014, 7, 6153–6163. (c) Wan, J.-P.; Wang, H.; Liu, Y.; Ding, H.; Org. Lett.
2014, 1, 5160–5163. (d) Sharma, U.; Naveen, T.; Maji, A.; Manna, S.; Maiti, D. Angew.
Chem. Int. Ed. 2013, 52, 12669–12673. (e) Yuan, H.; Bi, K.-J.; Li, B.; Yue, R.-C.; Ye, J.;
Shen, Y.-H.; Shan, L.; Jin, H.-Z.; Sun, Q.-Y.; Zhang, W.-D. Org. Lett. 2013, 15, 4742–4745.
(f) Lee, D.-H.; Kwon, K.-H.; Yi, C. S. J. Am. Chem. Soc. 2012, 134, 7325–7328. (g) Hirano,
K.; Satoh, T.; Miura, M. Org. Lett. 2011, 13, 2395–2397. (h) Yagoubi, M.; Cruz, A. C. F.;
Nichols, P. L.; Elliott, R. L.; Willis, M. C. Angew. Chem. Int. Ed. 2010, 49, 7958–7962. (i)
Duan, S.-F.; Shen, G.; Zhang, Z.-B. Synthesis. 2010, 2547–2552.(j) Maimone, T. J.;
Buchwald, S. L. J. Am. Chem. Soc 2010, 132, 9990–9991.
[12] For selected examples on metal-free synthesis of benzofurans, see: (a) Liang, L.; Dong, X.;
Huang, Y.; Chem. Eur. J. 2017, 2 7882–7886. (b) Murakami, K.; Yorimitsu, H.; Osuka, A.
Angew. Chem. Int. Ed. 2014, 53, 7510–7513. (c) Okitsu, T.; Nakata, K.; Nishigaki, K.;
Michioka, N.; Karatani, M.; Wada, A. J. Org. Chem. 2014, 79, 5914–5920. (d) Kong, Y.;